 |
인쇄하기
취소
|
Dongwha Pharm wins US patent for quinolone derivative
Dongwha Pharm announced on January 13 that it won the U.S. patent (No. No. 6,649,763) related to optically active 7-pyrrolidinequinoline carboxylic acid derivative and its manufacturing method.
The company said that it invested two billion won for the development of a novel quinolone derivative.
The compound, which is now under preclinical trials, has an excellent antibacterial activity a...
The company said that it invested two billion won for the development of a novel quinolone derivative.
The compound, which is now under preclinical trials, has an excellent antibacterial activity a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.